Medicalgorithmics S.A.
MDG.WA · WSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.01 | 2.95 | 0.06 | -0.00 |
| FCF Yield | -13.70% | -6.89% | -8.65% | -25.96% |
| EV / EBITDA | -13.93 | 63.43 | 1.47 | -38.17 |
| Quality | ||||
| ROIC | -17.14% | 0.93% | 14.75% | -5.09% |
| Gross Margin | 84.86% | 39.34% | 80.30% | 234.07% |
| Cash Conversion Ratio | 0.81 | -0.31 | -0.21 | 0.04 |
| Growth | ||||
| Revenue 3-Year CAGR | -27.40% | -3.76% | -17.51% | -34.73% |
| Free Cash Flow Growth | -106.94% | -84.30% | 72.97% | -149.50% |
| Safety | ||||
| Net Debt / EBITDA | 0.11 | -8.86 | -0.88 | 0.92 |
| Interest Coverage | -101.46 | 4.01 | 63.51 | -7.10 |
| Efficiency | ||||
| Inventory Turnover | 0.39 | 2.80 | 1.41 | 0.00 |
| Cash Conversion Cycle | 814.19 | 157.45 | 314.82 | -110.09 |